Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Stoke Therapeutics granted stock options to purchase an aggregate of 103,020 shares to nine new employees as a material inducement to their employment. The options have an exercise price of $30.00 per share, equal to the closing price on June 15, 2026, and vest over a four-year period beginning one year from the vesting commencement date.
Key figures
- New employees
- 9
- Exercise price
- 30
- Shares granted
- 103020
- Vesting period years
- 4
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.